Synthesis and biological evaluation of certain α,β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents

Journal of Medicinal Chemistry

Volumn 43, Issue 15, 2000, Pages 2915-2921

  El Subbagh, Hussein I ^a   Abu Zaid, Suhair M ^a   Mahran, Mona A ^a   Badria, Farid A ^b   Al Obaid, Abdulrahman M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; APHIDICOLIN; CYTOTOXIC AGENT; PIPERIDONE DERIVATIVE; PYRIDINE DERIVATIVE; ZIDOVUDINE;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; GROWTH INHIBITION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION;

ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; HERPESVIRUS 1, HUMAN; HIV-1; HUMANS; KETONES; PIPERIDONES; PYRIDINES; PYRIMIDINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0034721143     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm000038m     Document Type: Article

References (33)

1. Dimmock, J. R.; Arora, V. K.; Duffy, M. J.; Reid, R. S.; Allen, T. M.; Kao, G. Y. Evaluation of Some N-acyl analogues of 3,5-Bis (arylidene)-4-piperidones for Cytotoxic Activity. Drug Des. Discovery 1992, 8, 291-299.
2. Dimmock, J. R.; Raghavan, S. K.; Logan, B. M.; Bigam, G. E. Antileukemic Evaluation of Some Mannich Bases Derived from 2-Arylidene-1,3-diketones. Eur. J. Med. Chem. 1983, 18, 248-254.
3. Baluja, G.; Municio, A. M.; Vega, S. Reactivity of Some α,β-Unsaturated Ketones Towards Sulfhydryl Compounds and Their Antifungal Activity. Chem. Ind. 1964, 2053-2054.
4. El-Barbary, A. A.; Khodair, A. I.; Pederson, E. B.; Nielsen, C. s-Glucosylated Hydantoins as New Antiviral Agents. J. Med. Chem. 1994, 37, 73-77.
5. Khodair, A. I.; El-Subbagh, H. I.; El-Emam, A. A. Synthesis of Certain 5-Substituted-2-Thiohydantoin Derivatives as Potential Cytotoxic and Antiviral Agents. Bull. Chim. Farm. 1997, 136, 561-567.
6. Al-Obaid, A. M.; El-Subbagh, H. I.; Khodair, A. I.; El-mazar, M. M. A. 5-Substituted-2-thiohydantoin Analogues as a Novel Class of Antitumor Agents. Anticancer Drugs 1996, 7, 873-880.
7. Lorand, T.; Deli, J.; Szabo, D.; Foldesi, A. Potentially Bioactive Pyrimidine Derivatives. Pharmazie 1985, 40, 53-539.
8. Temple, C.; Elliot, R.; Montogomery, J. Pyrido[2,3-d]pyrimidines. Synthesis of the 5-Deaza Analogues of Aminopterin, Methotrexate, Folic Acid. J. Org. Chem. 1982, 47, 761-764.
9. Li, L.; Wang, H.; Kuo, S.; Wu, T.; Mauger, A.; Lin, C. Antitumor Agents 155. Synthesis and Biological Evaluation of Substituted 2-Phenyl-4-Quinolones. J. Med. Chem. 1994, 37, 3400-3407.
10. Ambika, D. M.; Das, N. P. In Vitro Effects of Natural Plant Polyphenols on the Proliferation of Normal and Abnormal Human Lymphocytes and Their Secretion of Interleukin-2. Cancer Lett. 1993, 69, 191-196.
11. Cassady, J. M. Natural Products as a Source of Potential Cancer Chemopreventive Agents J. Nat. Prod. 1990, 53, 23-30.
12. Newmark, H. L. Plant Polyphenolics as Inhibitors of Mutational and Precarcinogenic Events. Can. J. Physiol. Pharmacol. 1986, 65, 461-466.
13. Ramanathan, R.; Tan, C. H.; Das, N. P. Cytotoxic Effects of Polyphenols and Fat Soluble Vitamins on Malignant Human Cultured Cells. Cancer Lett. 1992, 62, 217-224.
14. Narborne, J. B.; Maby, T. J. The Flavonoids: Advances in Research; Chapman and Hall: London, 1982.
15. Elliott, A. J.; Scheiber, S. A.; Thomas, C.; Pardini, R. S. Inhibition of Glutathione Reductase by Flavonoids: A Structure-activity Study. Biochem. Pharmacol. 1992, 44, 1603-1616.
16. Kuppusamy, U. R.; Das, N. P. Effect of Flavonoids on Cyclic AMP Phosphodiesterase and Lipid Mobilization in Rat Adipocytes. Biochem. Pharmacol. 1992, 44, 1307-1312.
17. Suolinna, E. M.; Buchskaum, R. N.; Racker, E. The Effect of Flavonoids on Aerobic Glycolysis and Growth of Tumor Cells. Cancer Res. 1976, 35, 1865-1870.
18. Haenszel, W.; Locke, R. B.; Segi, M. A Case Control Study of Large Bowel Cancer in Japan. J. Natl. Cancer Inst. 1980, 64, 17-23.
19. Wilpart, M. Dietary Fats and Fiber and Experimental Carcinogenesis: A Critical Review of Published Evidences. In Causation and Prevention of Colorectal Cancer; ECP Symposium; Faivre, J., Hill, M. J., Eds.; Excerpta Medica: Amsterdam, 1987.
20. Chin, C. Y.; Nagaratnam, P. D. Cytotoxic Effect of Butein on Human Colon Adenocarcinoma Cell Proliferation. Cancer Lett. 1994, 82, 65-72.
21. Aizu, E.; Nakadate, T.; Yamamoto, S.; Kato, R. New Lipoxygenase Inhibitors Lacking Protein Kinase C Inhibitory Effects. Carcinogenesis 1986, 7, 1809-1812.
22. Beutler, J. A.; Cardellina, J. H.; Gray, G. N.; Prather, T. R.; Shaemaker, R. H.; Boyd, M. R. Two New Cytotoxic Chalcones from Calythropsis Aurea. J. Nat. Prod. 1993, 56, 1718-1722.
23. Vincenzo, R. De; Scambia, G.; Panici, P.; Ranelletti, F.; Mancuso, S. Effect of Synthetic and Natural Occurring Chalcones on Ovarian Cancer Cell Growth. Anti-Cancer Drug Des. 1995, 10, 481-490.
24. Artico, M.; R. Santo, Di; Costi, R.; Novellino, E.; Greco, G.; Massa, S.; Tramontane, E.; Marongui, M.; De Montis, A.; La Colla, P. Geometrically and Conformationally Restrained Cinnamoyl Compounds as Inhibitors of HIV-1 Integrase. J. Med. Chem. 1998, 41, 3948-3960.
25. Zhao, H.; Neamatic, N.; Hong, H. Coumarine-Based Inhibitors of HIV Integrase. J. Med. Chem. 1997, 40, 242-249.
26. Skulnick, H. I.; Johnson, P. D.; Aristoff, P. A. Structure-Based Design of Nonpeptidic HIV Protease Inhibitors. J. Med. Chem. 1997, 40, 1149-1164.
27. Krapcho, J.; Turk, C. F. Pharmaceutical 7-benzylidene-3,3a,4,5,6,7-hexahydro-3-phenyl-2H-pyrazolo[4,3-c]pyridines. Ger. Offen. 2,411,499, Sept 26, 1974; Chem. Abstr. 1975, 4248c.
28. El-Kashef, H. S.; Geies, A. A.; Kamal, El-Dean, A. M.; Abdel-Hafez, A. A. Synthesis of thieno[2,3-c]pyridines and related heterocyclic systems. J. Chem. Technol. Biotechnol. 1993, 57, 15-19.
29. Hufford, C. D.; Badria, F. A.; Abou-Karam, M.; Shier, W. T.; Rogers, R. D. Preparation, Characterization and Antiviral Activity of Microbial Metabolites of Stemodin. J. Nat. Prod. 1991, 54, 1543-1552.
30. Weislow, O. S.; Kiser, R.; Fine, D.; Bader, J.; Shoemaker, R. H.; Boyd, M. R. New Soluble-formazan Assay for HIV-1 Cytopathic Effects. J. Natl. Cancer Inst. 1989, 81, 577-586.
31. Grever, M.; Schepartz, S.; Chabner, B. The National Cancer Institute Cancer Drug Discovery and Development Program. Semin Oncol. 1992, 19, 622-638.
32. Monks, A.; Scudiero, D.; Skehan, P.; et al. Feasibility of a High-Flux Anticancer Drug Screen Utilizing a Derive Panel of Human Tumor Cell Lines in Culture. J. Natl. Cancer Inst. 1991, 83, 757-766.
33. Boyd, M.; Paull, K. Some Practical Considerations and Applications of the National Cancer Institute in Vitro Anticancer Drug Discovery Screen. Drug Dev. Res. 1995, 34, 91-109.